SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-070114
Filing Date
2024-06-11
Accepted
2024-06-10 21:09:56
Documents
14
Period of Report
2024-06-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416817d1_8k.htm   iXBRL 8-K 40792
2 EXHIBIT 3.1 tm2416817d1_ex3-1.htm EX-3.1 6584
  Complete submission text file 0001104659-24-070114.txt   226327

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20240607.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20240607_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20240607_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2416817d1_8k_htm.xml XML 3797
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 241034470
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)